Source: Annals of the Rheumatic Diseases. Unidade: FM
Subjects: ANTICORPOS MONOCLONAIS (EFICIÊNCIA;SEGURANÇA), ARTRITE REUMATOIDE, MÉTODO DUPLO-CEGO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNNER, Hermine I. et al. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, v. 74, n. 6, p. 1110-1117, 2015Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2014-205351. Acesso em: 18 ago. 2024.APA
Brunner, H. I., Ruperto, N., Zuber, Z., Keane, C., Harari, O., Kenwright, A., et al. (2015). Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial. Annals of the Rheumatic Diseases, 74( 6), 1110-1117. doi:10.1136/annrheumdis-2014-205351NLM
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial [Internet]. Annals of the Rheumatic Diseases. 2015 ; 74( 6): 1110-1117.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1136/annrheumdis-2014-205351Vancouver
Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, Lu P, Cuttica R, Keltsev V, Xavier RM, Calvo I, Nikishina I, Rubio-Pérez N, Alexeeva E, Chasnyk V, Horneff G, Opoka-Winiarska V, Quartier P, Silva CA, Silverman E, Spindler A, Baildam E, Gámir ML, Martin A, Rietschel C, Siri D, Smolewska E, Lovell D, Martini A, De Benedetti F. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial [Internet]. Annals of the Rheumatic Diseases. 2015 ; 74( 6): 1110-1117.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1136/annrheumdis-2014-205351